Asia Pacific Enteral Nutrition Market Forecast to 2030 - Regional Analysis - by Product Type, Application, Age Group, and Distribution Channel

Description

List of Tables

The Asia Pacific enteral nutrition market was valued at US$ 1,791.10 million in 2022 and is expected to reach US$ 2,942.72 million by 2030; it is estimated to grow at a CAGR of 6.4% from 2022 to 2030.

Strategic Initiatives by Key Market Players Fuel Asia Pacific Enteral Nutrition Market

Companies operating in the enteral nutrition market continuously focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches. These help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. A few of the noteworthy developments in the enteral nutrition market are mentioned below:

In June 2022, Nestle Health Science acquired The Better Health Company (TBHC) from CDH Investments and TBHC's founding shareholders. The acquisition includes the GO Healthy brand; vitamin and supplement lineups; Egmont, the Manuka honey brand; and New Zealand Health Manufacturing, an Auckland-based manufacturing facility for vitamins, minerals, and supplements. The acquisition helped Nestle Health Science strengthen and expand its presence in New Zealand, Australia, and other Asia Pacific countries.
In September 2021, Abbott introduced plant-based protein and organic food ingredients-PediaSure Harvest and Ensure Harvest-for people relying on feeding tubes. Harvest products can be used as sole-source nutrition or a supplement to satisfy daily nutrition requirements.
In October 2020, Nutricia (part of Danone) acquired Real Food Blends. The company brings unique and nutritious choices to children and adults dependent on feeding tubes, in line with its real food blends mission.
Therefore, introducing products such as ready-to-drink and ready-to-use nutritional supplements, the development of innovative products targeting various health issues, and strategic moves such as expansions and acquisitions allow companies in the enteral nutrition market to create new or improved products and new business to remain competitive in the market. Thus, such strategic growth initiatives create significant growth opportunities in the market.

Asia Pacific Enteral Nutrition Market Overview

The Asia Pacific enteral nutrition market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The factors contributing to the market progress in this region include the rising prevalence of chronic diseases and the growing presence of market players across the region, conferring the highest manufacturing of enteral nutrition products. Furthermore, supportive government initiatives and research in the field of nutrition boost market growth. Countries such as Australia, India, and South Korea are estimated to witness various growth opportunities due to the rising development in the healthcare sector. In addition, governments of these countries are increasing their efforts to provide enteral and parenteral nutrition.

The rising prevalence of neurological diseases and the growing adoption of enteral nutrition are boosting the market's growth. China has experienced a significant rise in the elderly population. Stroke is the leading cause of death among older people across the country. According to the study published in Elsevier, in 2020, 17.8 million cases of stroke, 3.4 million new strokes, and 2.3 million stroke-related deaths were reported. The factors that have affected the numbers are the support of the government to educate the public on stroke prevention, better public knowledge of stroke, improved treatment options and medical technology, and improved healthcare coverage and healthcare environment, among others. Stroke is the most common cause of acute dysphagia, which may lead to malnutrition and impact the quality of life. Tube feeding of critically ill stroke patients was implemented as an enteral nutrition improvement strategy in China.

Asia Pacific Enteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Enteral Nutrition Market Segmentation

The Asia Pacific enteral nutrition market is segmented based on product type, application, age group, distribution channel, and country.

Based on product type, the Asia Pacific enteral nutrition market is bifurcated into general and disease specific. The general segment held a larger Asia Pacific enteral nutrition market share in 2022.

In terms of application, the Asia Pacific enteral nutrition market is segmented into gastrointestinal disorders, metabolic/inborn errors of metabolism, food allergy, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment held the largest Asia Pacific enteral nutrition market share in 2022.

Based on age group, the Asia Pacific enteral nutrition market is bifurcated into adult and pediatric. The adult segment held a larger Asia Pacific enteral nutrition market share in 2022.

By distribution channel, the Asia Pacific enteral nutrition market is segmented into hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest Asia Pacific enteral nutrition market share in 2022.

Based on country, the Asia Pacific enteral nutrition market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific enteral nutrition market in 2022.

Abbott Laboratories, Nestle SA, Danone SA, Fresenius SE & Co KGaA, B Braun SE, Reckitt Benckiser Group Plc, Royal FrieslandCampina NV, Arla Foods amba, Perrigo Co Plc, and Fonterra Co-Operative Group Ltd are some of the leading companies operating in the Asia Pacific enteral nutrition market.

Product Code: BMIRE00029864

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Enteral Nutrition Market - Key Industry Dynamics

4.1 Key Market Drivers:
- 4.1.1 Increasing Prevalence of Gastrointestinal Diseases
- 4.1.2 Rising Cases of Malnutrition and Premature Births
4.2 Market Restraints
- 4.2.1 Complications Associated with Enteral Feeding Systems
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives by Key Market Players
4.4 Future Trends
- 4.4.1 Specific Formulations and Plant-Based Nutrition Products
4.5 Impact Analysis

5. Enteral Nutrition Market - Asia Pacific Market Analysis

5.1 Asia Pacific Enteral Nutrition Market Revenue (US$ million), 2022 - 2030

6. Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 - by Product Type

6.1 Overview
6.2 Asia Pacific Enteral Nutrition Market Revenue Share, by Product Type 2022 & 2030 (%)
6.3 General
- 6.3.1 Overview
- 6.3.2 General: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.3.2.1 Asia Pacific Enteral Nutrition Market, by General
    - 6.3.2.1.1 Asia Pacific Enteral Nutrition Market, by Elemental Formula
6.4 Disease Specific
- 6.4.1 Overview
- 6.4.2 Disease Specific: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 Asia Pacific Enteral Nutrition Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Gastrointestinal Disorder
- 7.3.1 Overview
- 7.3.2 Gastrointestinal Disorder: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Metabolic/Inborn Errors of Metabolism
- 7.4.1 Overview
- 7.4.2 Metabolic/Inborn Errors of Metabolism: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Allergy
- 7.5.1 Overview
- 7.5.2 Allergy: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Renal Disease
- 7.6.1 Overview
- 7.6.2 Renal Disease: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Liver Disease
- 7.7.1 Overview
- 7.7.2 Liver Disease: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Oncology
- 7.8.1 Overview
- 7.8.2 Oncology: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.9 Neurology
- 7.9.1 Overview
- 7.9.2 Neurology: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.10 Others
- 7.10.1 Overview
- 7.10.2 Others: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 - by Age Group

8.1 Overview
8.2 Asia Pacific Enteral Nutrition Market Revenue Share, by Age Group 2022 & 2030 (%)
8.3 Adult
- 8.3.1 Overview
- 8.3.2 Adult: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Pediatric
- 8.4.1 Overview
- 8.4.2 Pediatric: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 - by Distribution Channel

9.1 Overview
9.2 Asia Pacific Enteral Nutrition Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.3 Hospital Pharmacies
- 9.3.1 Overview
- 9.3.2 Hospital Pharmacies: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Retail Stores
- 9.4.1 Overview
- 9.4.2 Retail Stores: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
9.5 E-Commerce
- 9.5.1 Overview
- 9.5.2 E-Commerce: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Enteral Nutrition Market - Country Analysis

10.1 Asia Pacific Enteral Nutrition Market, Revenue and Forecast to 2030
- 10.1.1 Asia Pacific Enteral Nutrition Market by Country
  - 10.1.1.1 China
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 China Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
    - 10.1.1.1.3 China Enteral Nutrition Market, by Product Type
    - 10.1.1.1.3.1 China Enteral Nutrition Market, by General
    - 10.1.1.1.3.1.1 China Enteral Nutrition Market, by Elemental Formula
    - 10.1.1.1.4 China Enteral Nutrition Market, by Application
    - 10.1.1.1.5 China Enteral Nutrition Market, by Age Group
    - 10.1.1.1.6 China Enteral Nutrition Market, by Distribution Channel
  - 10.1.1.2 Japan
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Japan Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
    - 10.1.1.2.3 Japan Enteral Nutrition Market, by Product Type
    - 10.1.1.2.3.1 Japan Enteral Nutrition Market, by General
    - 10.1.1.2.3.1.1 Japan Enteral Nutrition Market, by Elemental Formula
    - 10.1.1.2.4 Japan Enteral Nutrition Market, by Application
    - 10.1.1.2.5 Japan Enteral Nutrition Market, by Age Group
    - 10.1.1.2.6 Japan Enteral Nutrition Market, by Distribution Channel
  - 10.1.1.3 India
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 India Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
    - 10.1.1.3.3 India Enteral Nutrition Market, by Product Type
    - 10.1.1.3.3.1 India Enteral Nutrition Market, by General
    - 10.1.1.3.3.1.1 India Enteral Nutrition Market, by Elemental Formula
    - 10.1.1.3.4 India Enteral Nutrition Market, by Application
    - 10.1.1.3.5 India Enteral Nutrition Market, by Age Group
    - 10.1.1.3.6 India Enteral Nutrition Market, by Distribution Channel
  - 10.1.1.4 Australia
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Australia Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
    - 10.1.1.4.3 Australia Enteral Nutrition Market, by Product Type
    - 10.1.1.4.3.1 Australia Enteral Nutrition Market, by General
    - 10.1.1.4.3.1.1 Australia Enteral Nutrition Market, by Elemental Formula
    - 10.1.1.4.4 Australia Enteral Nutrition Market, by Application
    - 10.1.1.4.5 Australia Enteral Nutrition Market, by Age Group
    - 10.1.1.4.6 Australia Enteral Nutrition Market, by Distribution Channel
  - 10.1.1.5 South Korea
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 South Korea Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
    - 10.1.1.5.3 South Korea Enteral Nutrition Market, by Product Type
    - 10.1.1.5.3.1 South Korea Enteral Nutrition Market, by General
    - 10.1.1.5.3.1.1 South Korea Enteral Nutrition Market, by Elemental Formula
    - 10.1.1.5.4 South Korea Enteral Nutrition Market, by Application
    - 10.1.1.5.5 South Korea Enteral Nutrition Market, by Age Group
    - 10.1.1.5.6 South Korea Enteral Nutrition Market, by Distribution Channel
  - 10.1.1.6 Rest of Asia Pacific
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 Rest of Asia Pacific Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
    - 10.1.1.6.3 Rest of Asia Pacific Enteral Nutrition Market, by Product Type
    - 10.1.1.6.3.1 Rest of Asia Pacific Enteral Nutrition Market, by General
    - 10.1.1.6.3.1.1 Rest of Asia Pacific Enteral Nutrition Market, by Elemental Formula
    - 10.1.1.6.4 Rest of Asia Pacific Enteral Nutrition Market, by Application
    - 10.1.1.6.5 Rest of Asia Pacific Enteral Nutrition Market, by Age Group
    - 10.1.1.6.6 Rest of Asia Pacific Enteral Nutrition Market, by Distribution Channel

11. Enteral Nutrition Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Enteral Nutrition Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Nestle SA
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Danone SA
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Fresenius SE & Co KGaA
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 B Braun SE
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Reckitt Benckiser Group Plc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Royal FrieslandCampina NV
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Arla Foods amba
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Perrigo Co Plc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Fonterra Co-Operative Group Ltd
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms